KRAS and lung cancer: To decipher the mechanism of how GR inhibits PI3K-AKT and MAPK (MEK1/2, p38) signaling, the authors found that apo-GR colocalizes and interacts with wt and mutant K-RAS in the cytoplasm of mouse embryonic fibroblasts and human lung cancer cells.